Mergers & Acquisitions Mergers & Acquisitions

Tech, pharma, biotech killer acquisitions prompted expanded powers, EU merger chief says

By Nicholas Hirst and Natalie McNelis
  • 26 Mar 2021 13:20
  • 07 Apr 2021 10:43
Technology, pharmaceutical and biotech companies' acquisitions of tiny but innovative challengers have created "unease" at the EU's merger regulator, the bloc's competition boss said today as she outlined an expansion to the EU's powers to review deals.

"We have an increasing unease with the kind of transaction where you have a really big

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments

TAKE A FREE TRIAL

Latest News